CSIMarket
 


Cell Medx Corp.  (CMXC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CMXC's Net Income Growth by Quarter and Year

Cell Medx.'s Net Income results by quarter and year




CMXC Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter May - -0.14 -0.24 0.39
III Quarter February - -0.39 -0.30 -0.30
II Quarter November -0.30 -0.13 -0.18 -1.06
I Quarter August -0.25 -0.24 -0.83 -0.28
FY   -0.55 -0.90 -1.55 -1.25



CMXC Net Income second quarter 2020 Y/Y Growth Comment
Cell Medx Corp. in the second quarter recorded net loss of $ -0.30 millions.

According to the results reported in the second quarter, Cell Medx Corp. achieved the best Net Income growth in Biotechnology & Drugs industry. While Cell Medx Corp.' s Net Income no change of % ranks overall at the positon no. in the second quarter.




CMXC Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter May - - - -
III Quarter February - - - -
II Quarter November - - - -
I Quarter August - - - -
FY   - - - -

Financial Statements
Cell Medx.'s second quarter 2020 Net Income $ -0.30 millions CMXC's Income Statement
Cell Medx.'s second quarter 2019 Net Income $ -0.13 millions Quarterly CMXC's Income Statement
New: More CMXC's historic Net Income Growth >>


CMXC Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter May - - - -
III Quarter February - - - -
II Quarter November - - - -
I Quarter August - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Cell Medx.'s Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CMXC's II. Quarter Q/Q Net Income Comment
II. Quarter 2020 results of -0.30 millions by Cell Medx Corp. come out even less good compare to the net loss -0.25 millions in the previous quarter.

Within Biotechnology & Drugs industry Cell Medx Corp. achieved highest sequential Net Income growth. While Cell Medx.'s Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CMXC's II. Quarter Q/Q Net Income Comment
Current results of -0.30 millions by Cell Medx Corp. appear even more unfavourable if you take a look at -0.25 millions net loss in the previous quarter.

Within Biotechnology & Drugs industry Cell Medx Corp. achieved highest sequential Net Income growth. While Cell Medx.'s Net Income growth quarter on quarter, overall rank is .


Cell Medx.'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
Cumulative Net Income 12 Months Ending $ -1.08 $ -0.91 $ -0.91 $ -1.55 $ -0.92
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Cell Medx Corp.' has realized cumulative trailing twelve months net loss of $ -1 millions in the Nov 30 2019 period.
The business is worsening as the cumulative net loss is getting bigger from $ -0.91 millions in the twelve months ending a quarter before and $ -0.25 millions for the twelve months ending in the quarter a year ago.

Cell Medx Corp. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Cell Medx Corp.' has realized cumulative trailing twelve months net loss of $ -1 millions in the Nov 30 2019 period.
The business is worsening as the cumulative net loss is inflating from $ -0.91 millions for the period from Aug 31 2019 to Feb 28 2018 and $ -0.25 millions for the twelve months ending in the quarter a year ago Gabriel  J. Williams mentioned.

Cell Medx Corp. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
CMXC's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for CMXC's Competitors
Net Income Growth for Cell Medx.'s Suppliers
Net Income Growth for CMXC's Customers

You may also want to know
CMXC's Annual Growth Rates CMXC's Profitability Ratios CMXC's Asset Turnover Ratio CMXC's Dividend Growth
CMXC's Roe CMXC's Valuation Ratios CMXC's Financial Strength Ratios CMXC's Dividend Payout Ratio
CMXC's Roa CMXC's Inventory Turnover Ratio CMXC's Growth Rates CMXC's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Nov 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Nov 30 2019


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HJLI's Profile

Stock Price

HJLI's Financials

Business Description

Fundamentals

Charts & Quotes

HJLI's News

Suppliers

HJLI's Competitors

Customers & Markets

Economic Indicators

HJLI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071